Continue to meet or exceed healthcare partners’ expectations by providing on-time test results approximately 92 percent of the time.
In August CTS begins source plasma testing as a new line of business to one of the largest plasma fr...
As a component of the CTS Business Continuity Plan, today all 6 labs began using the same laboratory...
Transitioned all 5 CTS labs from an investigational new drug (IND) to a licensed pooled Babesia test...
In October, due to demand from existing healthcare partners, CTS began testing blood donors for anti...
CTS Tampa lab implements Dengue testing on behalf of a healthcare partner in an endemic area.
Transitioned all 6 CTS labs from an investigational new drug (IND) to a licensed Zika test, and anno...